Related Experiment Video
Updated: Jul 20, 2025

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
Hilary Whitworth1, Lauren A Beslow2, Rebecca A Hubbard3
1Division of Hematology, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Insights
Infants with unprovoked venous thromboembolism (VTE) have a low recurrence rate but face significant long-term risks of organ damage, including neurological and kidney issues.
Area of Science:
- Pediatric Thrombosis Research
- Neonatal and Infant Health Outcomes
- Vascular Medicine
Background:
- Infants under 1 year have a higher venous thromboembolism (VTE) rate than older children.
- Unprovoked VTE in this age group is rare, with limited data on recurrence and long-term consequences.
- Most infant VTE cases are associated with additional prothrombotic risk factors.
Purpose of the Study:
- To determine the recurrence rate of unprovoked VTE in infants.
- To evaluate long-term end-organ outcomes in infants with intracranial and renal vein thrombosis.
- To assess anticoagulation duration and outcomes in this pediatric population.
Main Methods:
- Retrospective cohort study of infants (<1 year) with unprovoked VTE (2003-2021).
- Kaplan-Meier analysis for time to recurrence and anticoagulation duration.
- Assessment of neurologic outcomes using the pediatric stroke outcome measure.
- Evaluation of kidney function using estimated glomerular filtration rates.
Main Results:
- Forty infants with VTE (intracranial, renal, portal, extremity) were followed for a median of 4.7 years.
- One recurrent VTE event occurred over 237 person-years (incidence rate: 4 per 1000 person-years).
- 40% of infants with intracranial thrombosis had moderate/severe neurologic outcomes; two-thirds with renal vein thrombosis had abnormal kidney function.
Conclusions:
- Infants with unprovoked VTE exhibit a low risk of recurrence.
- Significant end-organ morbidity, particularly neurological and renal complications, is observed in this cohort.
- Long-term monitoring is crucial for infants experiencing unprovoked VTE.
Background:
Although children aged <1 year have a relatively high rate of venous thromboembolism (VTE) compared to older children, most have additional prothrombotic risk factors. Unprovoked VTE is rare, and little is known about this population, particularly the risk of recurrent VTE.
Objectives:
We aimed to determine the rate of recurrent VTE in infants with prior unprovoked VTE and evaluate long-term, end-organ outcomes for infants with renal and intracranial vein thrombosis.
Methods:
Infants <1 year of age with an unprovoked VTE between 2003 and 2021 at a single institution were included. Time to recurrent event and anticoagulation duration were summarized using the Kaplan-Meier estimator. Neurologic outcomes were summarized with the pediatric stroke outcome measure for infants with cerebral sinovenous, medullary, or cortical vein thrombosis. Kidney outcomes were summarized with estimated glomerular filtration rates for infants with renal vein thrombosis. Anticoagulation was summarized.
Results:
Forty infants with intracranial, renal, portal, and extremity VTE met the inclusion criteria and were followed for a median of 4.7 years (IQR, 2.1-8.5). Most VTE events occurred during the first month of life. There was 1 recurrent event in 237 person-years of follow-up (incidence rate, 4 per 1000 [95% CI, 0.6-29.9] person-years). In outpatient follow-up, 40% of infants with intracranial thrombosis met criteria for moderate or severe neurologic outcomes and two-thirds of infants with a prior renal vein thrombosis had abnormal kidney function (estimated glomerular filtration rate < 90 mL/min/1.73 m2).
Conclusion:
There is a low rate of recurrent VTE but significant end-organ morbidity in infants with unprovoked VTE.
More Related Videos
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care